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mitogen response was lower in H-HD than in healthy staff
and travellers (7.56 IU/mL vs 20.15 IU/mL, p < 0.001).
Conclusion: The IGRA test gives fewer indeterminate and
positive results than we expected from overseas reports.14th International Congress on Infectious Diseases (ICID) Abs
59.020
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Background: The rapid identiﬁcation of mycobacteria
from culture-positive Mb/Bact bottles is an important clini-
cal issue. Furthermore, the availability of a non-expensive,
technically simple, and accurate method also would beneﬁt
mycobacterial laboratories in developing countries. In this
study, we aimed to develop an assay allowing the identiﬁ-
cation of the Mycobacterium tuberculosis complex (MTBC)
and other frequently isolated nontuberculous mycobacte-
ria (NTM) directly from positive Mb/Bact (Organon-Teknika)
bottles. A multiplex PCR focusing the hsp65 gene, and the
IS6110 was done and evaluated for its efﬁciency compared
to PRA identﬁcation, and PNB inhibition.
Methods: Mycobacterial strains were grown from clin-
ical samples and preserved in solid media (LJ). A panel
of 91 M. tuberculosis strains, and 26 Non-Tuberculous-
Mycobacteria were submitted to the following identiﬁcation
techniques: a) hsp65 gene ampliﬁcation followed by restric-
tion (PRA); b) p-Nitrobenzoic acid (PNB) growth inhibition
in liquid media (Mb/Bact); 3) Multiplex-PCR, using two sets
of primers: TB284/TB850 (IS6110 MTC spciﬁc primers), and
TB11/TB12 (65 kD antigen, Mycobacterium genus speciﬁc
primers). The mycobacteria was inactivated being heated at
80oC for 20min before DNA extraction. DNA was extracted
by the freezing and thawing method. 50l of the the super-
natant was used for ampliﬁcation. Identiﬁcation using hsp65
restriction was done according to international protocols
(Telenti et al, 1993), and considered the gold-standard. PNB
was added to liquid Mb/Bact bottles to a ﬁnal concentration
of 500g/ml. p-aminobenzoic acid, and the Mycobacterial
concentration was adjusted to the MacFarland 1 standard.
Results: The hsp65 restriction analysis identiﬁed all
Mycobacteria tested as: M.tuberculosis (61 strains),
M.avium, M.intracellulare, M.fortuitum, M.abscessus,
M.gordonae, M.szulgai. There was 100% agreement
between the tests performedts e311
Conclusion: A simple and inexpensive Multiplex-PCR as
escribed here, can readly distinguish among M. tuberculo-
is Complex strains, and Non-Tuberculous Mycobacteria.
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dentiﬁcation and treatment of latent tuberculosis infec-
ion in haemodialysis patients in New Zealand
. Verrall, M. Leikis, J. Hildreth, N. Raymond, T.
lackmore ∗
Capital and Coast DHB, Wellington, New Zealand
Background: International and local reports indicate that
uberculosis (TB) is a major issue in haemodialysis units
ecause of high rates, difﬁcult and late diagnosis, high
orbidity and mortality. Moreover, there is potential for
osocomial spread. The Mantoux test is unreliable in renal
isease, and appears to have lead to diagnostic nihilism
ith respect to latent TB infection (LTBI): no treatment of
TBI had been employed previously in our unit. The aims of
his study were to describe the epidemiology of active TB
ithin renal patients in the greater Wellington Region and
o develop a LTBI testing and treating algorithm using an
nterferongamma release assay (IGRA)
Methods: A ten year review of notiﬁcation data and clin-
cal records was used to identify and describe renal patients
ith active TB. All patients receiving hospital haemodialysis
H-HD) were screened using QUANTIFERON-Gold (Cellis-
is, Australia). Chest radiographs and clinical notes were
eviewed.
Results: Seven cases of active TB in H-HD patients were
dentiﬁed, approximating an incidence of 1.2/100 new dial-
sis patients. The overall annual incidence in New Zealand is
0.3/100,000. Six patients died (86% mortality), but mostly
his was not directly due to TB. All 65 H-HD patients were
creened for LTBI, 66% of whom were born outside NZ. Over-
ll 6 (9%) were positive and all but one were from overseas,
igh prevalence, countries. Three results were repeatedly
ndeterminate due to weak mitogen test results. The mean
